First Affirmative Financial Network Has $273,000 Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)

First Affirmative Financial Network grew its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) by 29.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 20,602 shares of the company’s stock after buying an additional 4,736 shares during the quarter. First Affirmative Financial Network’s holdings in Takeda Pharmaceutical were worth $273,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in TAK. Hexagon Capital Partners LLC increased its stake in Takeda Pharmaceutical by 34.3% during the 3rd quarter. Hexagon Capital Partners LLC now owns 4,419 shares of the company’s stock valued at $63,000 after purchasing an additional 1,129 shares in the last quarter. Gold Investment Management Ltd. increased its position in shares of Takeda Pharmaceutical by 2.0% during the third quarter. Gold Investment Management Ltd. now owns 73,204 shares of the company’s stock worth $1,049,000 after acquiring an additional 1,428 shares in the last quarter. Smithfield Trust Co raised its holdings in shares of Takeda Pharmaceutical by 76.9% in the 3rd quarter. Smithfield Trust Co now owns 3,428 shares of the company’s stock worth $49,000 after acquiring an additional 1,490 shares during the last quarter. Kovitz Investment Group Partners LLC lifted its position in Takeda Pharmaceutical by 7.0% in the 3rd quarter. Kovitz Investment Group Partners LLC now owns 25,456 shares of the company’s stock valued at $362,000 after acquiring an additional 1,670 shares in the last quarter. Finally, Aaron Wealth Advisors LLC boosted its stake in Takeda Pharmaceutical by 7.2% during the 4th quarter. Aaron Wealth Advisors LLC now owns 25,000 shares of the company’s stock valued at $331,000 after purchasing an additional 1,670 shares during the last quarter. Institutional investors own 9.17% of the company’s stock.

Takeda Pharmaceutical Stock Performance

Shares of Takeda Pharmaceutical stock opened at $13.68 on Friday. The company has a market cap of $43.51 billion, a PE ratio of 23.58, a price-to-earnings-growth ratio of 0.25 and a beta of 0.51. The company has a quick ratio of 0.77, a current ratio of 1.28 and a debt-to-equity ratio of 0.64. Takeda Pharmaceutical Company Limited has a 52 week low of $12.57 and a 52 week high of $15.08. The business has a 50 day moving average price of $13.30 and a 200-day moving average price of $13.89.

Takeda Pharmaceutical (NYSE:TAK) last issued its quarterly earnings data on Thursday, January 30th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.08. Takeda Pharmaceutical had a return on equity of 10.00% and a net margin of 6.49%. Equities analysts anticipate that Takeda Pharmaceutical Company Limited will post 1.55 earnings per share for the current fiscal year.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.